{
    "Trade/Device Name(s)": [
        "Apieron INSIGHT\u2122 eNO System"
    ],
    "Submitter Information": "Apieron, Inc.",
    "510(k) Number": "K073265",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXA"
    ],
    "Summary Letter Date": "March 14, 2008",
    "Summary Letter Received Date": "March 6, 2008",
    "Submission Date": "November 16, 2007",
    "Regulation Number(s)": [
        "21CFR862.3080"
    ],
    "Regulation Name(s)": [
        "Breath nitric oxide test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Nitric oxide (eNO)"
    ],
    "Specimen Type(s)": [
        "Expired human breath"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Apieron INSIGHT eNO Monitor",
        "Sensor Cartridge"
    ],
    "Method(s)/Technology(ies)": [
        "Optical biosensor technology"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Apieron INSIGHT eNO System for quantitative measurement of exhaled nitric oxide in human breath as a marker for inflammation in asthma.",
    "Indications for Use Summary": "Quantitatively measures exhaled nitric oxide in expired human breath as a marker of inflammation in persons with asthma; suitable for children (8-17) and adults (18+); adjunct to established clinical assessments in physician office laboratory setting.",
    "fda_folder": "Toxicology"
}